Hand-held magnetic pulse device relieves migraines

Help for migraine sufferers in the form of a hand-held device is in the pipeline.

The small device delivers a painless magnetic pulse into the head which may offer some relief, according to a small study.

The therapy known as noninvasive transcranial magnetic stimulation, or TMS, sparks a magnetic pulse which, when held against a person's head, creates an electric current among the nerves cells of the brain.

This electric current disrupts migraines in the "aura" phase, before they trigger pain.

Though in many cases migraines strike without warning, some people experience an aura stage, which is marked by visual disturbances, such as flashes of light or zigzag lines, or other sensations such as tingling or numbness.

For the study the researchers from Ohio State University recruited 201 patients suffering from migraine with aura, then randomly assigned them to use the TMS device or a "fake" device the investigators used for comparison.

The patients were instructed to apply the device over the site of the migraine, at its onset and the researchers found that two hours after treatment, 39 percent of the TMS patients were pain-free, versus 22 percent of patients using the fake device.

Dr. Yousef Mohammad who led the study says the results were very significant and a much better response than is achieved with any other method or medication currently used.

Dr. Mohammad says by interfering with the aura phase of migraine, TMS essentially interrupts the "electrical storm" that culminates in migraine pain.

Some patients in the study also found the treatment eased migraine-related symptoms of nausea and sensitivity to light and sound.

Dr. Mohammad reported the findings at the annual meeting of the American Headache Society, last week in Boston.

The research was funded by NeuraLieve, the manufacturer of the TMS device used in the study and Dr. Mohammad serves on the company's board of directors.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triptans prove to be more effective for acute migraines than newer drugs